论文部分内容阅读
目的:观察邓老金福安汤治疗中晚期非小细胞肺癌(NSCLC)的疗效。方法:按照纳入标准,收集病例90例,采用简单随机的方法,将病例分成化疗组(Ⅰ组)、单纯中药组(Ⅱ组)、中西医综合组(Ⅲ组),各组均治疗2个疗程。然后观察患者临床症状改善情况、瘤体变化、免疫指标变化、血液流变学、生存质量改善情况、体重变化以及治疗过程中所致消化道反应、骨髓抑制等毒性反应,并进行比较。结果:中药组肿瘤缩小效果欠佳,但临床症状改善较明显,各项免疫指标增长较明显,血流变学也有改善,且无明显毒性反应。结论:邓老金福安汤确实具有良好的临床效果,能够改善中晚期非小细胞肺癌患者主要临床症状,提高患者免疫力,降低血液粘稠度,配合化疗时可减轻化疗毒副反应。
Objective: To observe the efficacy of Deng Lao Jin Fu An Tang in the treatment of advanced non-small cell lung cancer (NSCLC). Methods: According to the inclusion criteria, 90 cases were collected. The patients were divided into chemotherapy group (group Ⅰ), simple Chinese medicine group (group Ⅱ) and integrated traditional Chinese and western medicine group (group Ⅲ) Course of treatment. Then observe the clinical symptoms of patients with improvement, tumor changes, changes in immune indicators, hemorheology, quality of life improvement, weight changes and the treatment of gastrointestinal reactions caused by the reaction, bone marrow suppression and other toxic reactions, and compared. Results: The tumor shrinkage in traditional Chinese medicine group was not good, but the improvement of clinical symptoms was obvious. The immune indexes increased more obviously and hemorrheology was also improved with no obvious toxic reaction. Conclusion: Deng Lao Jin Fu An Tang indeed has a good clinical effect, can improve the main clinical symptoms of patients with advanced non-small cell lung cancer, improve patient immunity, reduce blood viscosity, with chemotherapy can reduce the side effects of chemotherapy.